• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • Product And Operating Company News Archive
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

< Prev | | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | .... 34 Next >
Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s Care

January 26, 2012

Janssen Research & Development, LLC Opens JANSSEN LABS at San Diego

January 17, 2012

Neutrogena Signs Leading Mexican Actress & Recording Artist Sandra Echeverria

January 13, 2012

First And Only Meter To Look For Patterns Of High And Low Blood Sugar And Alert Diabetes Patients Right On Screen

January 09, 2012

Janssen Therapeutics Announces Latest Recipients Of LINCC™ Funding Initiative

January 05, 2012

Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

December 29, 2011

< Prev | | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • Product And Operating Company News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

This section contains multiple pages. Click on each page number to advance the page.
< Prev | | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | .... 34 Next >
Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s Care

January 26, 2012

Janssen Research & Development, LLC Opens JANSSEN LABS at San Diego

January 17, 2012

Neutrogena Signs Leading Mexican Actress & Recording Artist Sandra Echeverria

January 13, 2012

First And Only Meter To Look For Patterns Of High And Low Blood Sugar And Alert Diabetes Patients Right On Screen

January 09, 2012

Janssen Therapeutics Announces Latest Recipients Of LINCC™ Funding Initiative

January 05, 2012

Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

December 29, 2011

< Prev | | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •